Cubist Systematic Strategies LLC Has $1.41 Million Position in AdvanSix $ASIX

by · The Cerbat Gem

Cubist Systematic Strategies LLC boosted its holdings in shares of AdvanSix (NYSE:ASIX – Free Report) by 65.6% during the first quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 62,299 shares of the company’s stock after buying an additional 24,690 shares during the period. Cubist Systematic Strategies LLC owned about 0.23% of AdvanSix worth $1,411,000 as of its most recent SEC filing.

Several other institutional investors and hedge funds also recently made changes to their positions in ASIX. Price T Rowe Associates Inc. MD boosted its stake in shares of AdvanSix by 18.8% in the 4th quarter. Price T Rowe Associates Inc. MD now owns 9,948 shares of the company’s stock valued at $284,000 after purchasing an additional 1,574 shares in the last quarter. Northern Trust Corp boosted its position in AdvanSix by 12.3% during the 4th quarter. Northern Trust Corp now owns 312,561 shares of the company’s stock worth $8,905,000 after acquiring an additional 34,236 shares during the last quarter. Ameriprise Financial Inc. boosted its position in AdvanSix by 0.3% during the 4th quarter. Ameriprise Financial Inc. now owns 135,127 shares of the company’s stock worth $3,850,000 after acquiring an additional 450 shares during the last quarter. Bank of America Corp DE boosted its position in AdvanSix by 38.0% during the 4th quarter. Bank of America Corp DE now owns 64,760 shares of the company’s stock worth $1,845,000 after acquiring an additional 17,823 shares during the last quarter. Finally, BOKF NA acquired a new position in AdvanSix during the 4th quarter worth approximately $217,000. Institutional investors and hedge funds own 86.39% of the company’s stock.

AdvanSix Stock Performance

Shares of ASIX stock opened at $21.20 on Monday. The business’s 50-day moving average price is $21.38 and its 200-day moving average price is $22.63. AdvanSix has a 12 month low of $17.97 and a 12 month high of $33.00. The firm has a market capitalization of $568.93 million, a price-to-earnings ratio of 7.46 and a beta of 1.64. The company has a current ratio of 1.35, a quick ratio of 0.66 and a debt-to-equity ratio of 0.29.

AdvanSix Dividend Announcement

The business also recently disclosed a quarterly dividend, which was paid on Tuesday, August 26th. Investors of record on Tuesday, August 12th were paid a $0.16 dividend. This represents a $0.64 dividend on an annualized basis and a dividend yield of 3.0%. The ex-dividend date of this dividend was Tuesday, August 12th. AdvanSix’s payout ratio is currently 22.54%.

Analyst Upgrades and Downgrades

Several research firms have recently commented on ASIX. Wall Street Zen downgraded AdvanSix from a “buy” rating to a “hold” rating in a report on Sunday, August 10th. Piper Sandler set a $32.00 price objective on AdvanSix in a research report on Monday, May 19th. One investment analyst has rated the stock with a Buy rating, According to data from MarketBeat.com, AdvanSix has an average rating of “Buy” and a consensus target price of $33.50.

Read Our Latest Stock Analysis on ASIX

AdvanSix Profile

(Free Report)

AdvanSix Inc engages in the manufacture and sale of polymer resins in the United States and internationally. It offers Nylon 6, a polymer resin, which is a synthetic material used to produce fibers, filaments, engineered plastics, and films. The company also provides caprolactam to manufacture polymer resins; ammonium sulfate fertilizers to distributors, farm cooperatives, and retailers; and acetone that are used in the production of adhesives, paints, coatings, solvents, herbicides, and engineered plastic resins, as well as other intermediate chemicals, including phenol, monoisopropylamine, dipropylamine, monoallylamine, alpha-methylstyrene, cyclohexanone, methyl ethyl ketoxime, acetaldehyde oxime, 2-pentanone oxime, cyclohexanol, sulfuric acid, ammonia, and carbon dioxide.

Read More